InspireMD, Inc. (NSPR) Stock Analysis

Company Overview

InspireMD, Inc. (NSPR) carries a market capitalisation of $39.96M. The company sits in the Healthcare sector, in the Medical Devices industry. The company reports 127 employees.

NSPR last closed at $0.85 on September 4, 2026. That is +$0.01 (+1.19%) against the previous close. Over the past 52 weeks the price has ranged from $0.63 to $2.57. The latest close sits 34.92% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $8.98M. Against the prior fiscal year total of $7.01M, that is a change of +28.11%. The same year closed with a net loss of $48.79M. Profit margin runs at 0%. That is 1.7 percentage points above the Medical Devices median of −1.69%. Earnings per share on a trailing basis come to −0.62.

Across the 4 fiscal years on file, revenue moves from $5.17M in 2022 to $8.98M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. The price-to-sales ratio is 3.69. On price-to-sales that is 23.86% above the Medical Devices median of 2.98. The medians here are taken across 151 Medical Devices companies that report the metric.

The trailing one-year price return is −65.16%. Measured over 10 years, that is −68.62% a year compounded. Beta against the wider market is reported at 0.82. Daily returns over the trailing 10 years annualize to a volatility of 112.91%.

Growth & Income

The record shows no dividend for NSPR.

So far in 2026 the price is −52.25%. Across the complete calendar years on file, 2023 returned +226.74% and 2018 returned −96.48%. Of the 9 complete calendar years on file, 1 finished higher.